Synthesis and biological evaluation of novel indole-2-one and 7-aza-2-oxindole derivatives as anti-inflammatory agents. 2014

Gaozhi Chen, and Lili Jiang, and Lili Dong, and Zhe Wang, and Fengli Xu, and Ting Ding, and Lili Fu, and Qilu Fang, and Zhiguo Liu, and Xiaoou Shan, and Guang Liang
Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Lishui, Zhejiang, People's Republic of China.

Sepsis, a typically acute inflammatory disease, is the biggest cause of death in ICU (intensive care unit). Novel anti-inflammatory alternatives are still in urgent need. In this study, we designed and synthesized 30 indole-2-one and 7-aza-2-oxindole derivatives based on the skeleton of tenidap, and their anti-inflammatory activity was determined by evaluating the inhibitory potency against lipopolysaccharide (LPS)-stimulated tumor necrosis factor (TNF)-α and interleukin (IL)-6 release in RAW264.7 macrophages. Quantitative SAR (structure-activity relationship) analysis revealed that a high molecular polarizability and low lipid/water partition coefficient (ALogP) in indole-2-one are beneficial for anti-inflammatory activity. Moreover, compounds 7i and 8e inhibited the expression of TNF-α, IL-6, COX-2, PGES, and iNOS in LPS-stimulated macrophages, and 7i exhibited a significant protection from LPS-induced septic death in mouse models. These data present a series of new indole-2-one compounds with potential therapeutic effects in acute inflammatory diseases.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000078183 Oxindoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl and a carbonyl at the pyrrole ring typically at the 2-position. Ajmalicine Oxindole,Ajmalicine Oxindoles,Ajmalicine-Type Oxindole,Ajmalicine-Type Oxindoles,Indolinone,Indolinone Derivative,Macroline Oxindole,Macroline Oxindoles,Macroline-Type Oxindole,Macroline-Type Oxindoles,Oxazolidinone Derivative,Oxindole Alkaloid,Oxindole Alkaloid Derivative,Oxindole Derivative,Indolinone Derivatives,Indolinones,Oxazolidinone Derivatives,Oxindole Alkaloid Derivatives,Oxindole Alkaloids,Oxindole Derivatives,Ajmalicine Type Oxindole,Ajmalicine Type Oxindoles,Alkaloid Derivative, Oxindole,Alkaloid, Oxindole,Derivative, Indolinone,Derivative, Oxazolidinone,Derivative, Oxindole,Derivative, Oxindole Alkaloid,Macroline Type Oxindole,Macroline Type Oxindoles,Oxindole, Ajmalicine,Oxindole, Ajmalicine-Type,Oxindole, Macroline,Oxindole, Macroline-Type,Oxindoles, Ajmalicine,Oxindoles, Ajmalicine-Type,Oxindoles, Macroline,Oxindoles, Macroline-Type
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents

Related Publications

Gaozhi Chen, and Lili Jiang, and Lili Dong, and Zhe Wang, and Fengli Xu, and Ting Ding, and Lili Fu, and Qilu Fang, and Zhiguo Liu, and Xiaoou Shan, and Guang Liang
January 2014, Medicinal chemistry (Shariqah (United Arab Emirates)),
Gaozhi Chen, and Lili Jiang, and Lili Dong, and Zhe Wang, and Fengli Xu, and Ting Ding, and Lili Fu, and Qilu Fang, and Zhiguo Liu, and Xiaoou Shan, and Guang Liang
April 2012, European journal of medicinal chemistry,
Gaozhi Chen, and Lili Jiang, and Lili Dong, and Zhe Wang, and Fengli Xu, and Ting Ding, and Lili Fu, and Qilu Fang, and Zhiguo Liu, and Xiaoou Shan, and Guang Liang
July 2017, European journal of medicinal chemistry,
Gaozhi Chen, and Lili Jiang, and Lili Dong, and Zhe Wang, and Fengli Xu, and Ting Ding, and Lili Fu, and Qilu Fang, and Zhiguo Liu, and Xiaoou Shan, and Guang Liang
June 2016, Chemical & pharmaceutical bulletin,
Gaozhi Chen, and Lili Jiang, and Lili Dong, and Zhe Wang, and Fengli Xu, and Ting Ding, and Lili Fu, and Qilu Fang, and Zhiguo Liu, and Xiaoou Shan, and Guang Liang
March 2009, Medicinal chemistry (Shariqah (United Arab Emirates)),
Gaozhi Chen, and Lili Jiang, and Lili Dong, and Zhe Wang, and Fengli Xu, and Ting Ding, and Lili Fu, and Qilu Fang, and Zhiguo Liu, and Xiaoou Shan, and Guang Liang
June 2013, European journal of medicinal chemistry,
Gaozhi Chen, and Lili Jiang, and Lili Dong, and Zhe Wang, and Fengli Xu, and Ting Ding, and Lili Fu, and Qilu Fang, and Zhiguo Liu, and Xiaoou Shan, and Guang Liang
June 2015, Bioorganic & medicinal chemistry letters,
Gaozhi Chen, and Lili Jiang, and Lili Dong, and Zhe Wang, and Fengli Xu, and Ting Ding, and Lili Fu, and Qilu Fang, and Zhiguo Liu, and Xiaoou Shan, and Guang Liang
January 2023, International journal of molecular sciences,
Gaozhi Chen, and Lili Jiang, and Lili Dong, and Zhe Wang, and Fengli Xu, and Ting Ding, and Lili Fu, and Qilu Fang, and Zhiguo Liu, and Xiaoou Shan, and Guang Liang
November 2015, Bioorganic & medicinal chemistry letters,
Gaozhi Chen, and Lili Jiang, and Lili Dong, and Zhe Wang, and Fengli Xu, and Ting Ding, and Lili Fu, and Qilu Fang, and Zhiguo Liu, and Xiaoou Shan, and Guang Liang
June 2012, Archives of pharmacal research,
Copied contents to your clipboard!